Related Experiment Video
Updated: Jan 1, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Cutaneous intestinal metaplasia: An unusual cause of peristomal complication with malignant potential
Daniel G Tinker1, Sammie Roberts1, M Yadira Hurley1
1Department of Dermatology, Saint Louis University School of Medicine, St. Louis, Missouri.
Abstract:
Peristomal ulcer with cutaneous intestinal metaplasia, defined by scattered colonic crypts within variably intact epidermis, is an exceedingly rare pathologic diagnosis, which possesses the potential to progress to primary adenocarcinoma. Herein, we report the third case of cutaneous intestinal metaplasia in a peristomal ulcer and emphasize the importance of diagnosis and surveillance when managing this rare entity.
Insights
Cutaneous intestinal metaplasia in peristomal ulcers is a rare diagnosis with potential to become adenocarcinoma. Early detection and monitoring are crucial for patient management.
Area of Science:
- Gastroenterology
- Pathology
- Dermatology
Background:
- Peristomal ulcers can develop in patients with ostomies.
- Cutaneous intestinal metaplasia (CIM) is a rare condition where skin near a stoma shows intestinal tissue characteristics.
- This condition has a potential link to cancer development.
Observation:
- This report details the third documented case of CIM in a peristomal ulcer.
- The diagnosis is characterized by the presence of colonic crypts within the skin.
- The epidermis may be variably intact in affected areas.
Findings:
- Cutaneous intestinal metaplasia in peristomal ulcers is an exceedingly rare pathologic finding.
- The presence of scattered colonic crypts within the epidermis defines this condition.
- This entity carries a risk of progressing to primary adenocarcinoma.
Implications:
- Accurate diagnosis of CIM in peristomal ulcers is critical.
- Regular surveillance is essential for patients with this rare condition.
- Prompt identification and management may prevent malignant transformation.
More Related Videos
28:15Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Renewal of Intestinal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...